These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12690260)

  • 41. Spherical sulfated cellulose adsorbs high-mobility-group box chromosomal protein 1 in vitro and in vivo.
    Suda K; Takeuchi H; Hagiwara T; Miyasho T; Yamada S; Inoue T; Okamoto M; Wada N; Saikawa Y; Fukunaga K; Hashimoto S; Yokota H; Maruyama I; Kitagawa Y
    ASAIO J; 2010; 56(3):210-4. PubMed ID: 20335795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of high-mobility group box-1 in renal ischemia and reperfusion injury and the effect of ethyl pyruvate.
    Chung KY; Park JJ; Kim YS
    Transplant Proc; 2008 Sep; 40(7):2136-8. PubMed ID: 18790172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HMGB1 preconditioning: therapeutic application for a danger signal?
    Klune JR; Billiar TR; Tsung A
    J Leukoc Biol; 2008 Mar; 83(3):558-63. PubMed ID: 17938274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is HMGB1 an osteocyte alarmin?
    Bidwell JP; Yang J; Robling AG
    J Cell Biochem; 2008 Apr; 103(6):1671-80. PubMed ID: 17948903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural basis for the proinflammatory cytokine activity of high mobility group box 1.
    Li J; Kokkola R; Tabibzadeh S; Yang R; Ochani M; Qiang X; Harris HE; Czura CJ; Wang H; Ulloa L; Wang H; Warren HS; Moldawer LL; Fink MP; Andersson U; Tracey KJ; Yang H
    Mol Med; 2003; 9(1-2):37-45. PubMed ID: 12765338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of high mobility group box-1 protein on immune cells and its regulatory mechanism.
    Luan YY; Yao FH; Zhang QH; Zhu XM; Dong N; Yao YM
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Nov; 28(6):548-54. PubMed ID: 23581184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The extracellular role of high mobility group box-1 protein in regulation of immune response].
    Tang LM; Lu ZQ; Yao YM
    Sheng Li Ke Xue Jin Zhan; 2011 Jun; 42(3):188-94. PubMed ID: 21932516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High mobility group box 1 prolongs inflammation and worsens disease in pneumococcal meningitis.
    Höhne C; Wenzel M; Angele B; Hammerschmidt S; Häcker H; Klein M; Bierhaus A; Sperandio M; Pfister HW; Koedel U
    Brain; 2013 Jun; 136(Pt 6):1746-59. PubMed ID: 23518713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease: lessons from animal models.
    Schaper F; Heeringa P; Bijl M; Westra J
    Curr Opin Rheumatol; 2013 Mar; 25(2):254-9. PubMed ID: 23249831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extracellular role of HMGB1 in inflammation and sepsis.
    Wang H; Yang H; Tracey KJ
    J Intern Med; 2004 Mar; 255(3):320-31. PubMed ID: 14871456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-mobility group box 1 (HMGB1) as a master regulator of innate immunity.
    Castiglioni A; Canti V; Rovere-Querini P; Manfredi AA
    Cell Tissue Res; 2011 Jan; 343(1):189-99. PubMed ID: 20835834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversing established sepsis with antagonists of endogenous high-mobility group box 1.
    Yang H; Ochani M; Li J; Qiang X; Tanovic M; Harris HE; Susarla SM; Ulloa L; Wang H; DiRaimo R; Czura CJ; Wang H; Roth J; Warren HS; Fink MP; Fenton MJ; Andersson U; Tracey KJ
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):296-301. PubMed ID: 14695889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular disease and high-mobility group box 1--is a new inflammatory killer in town?
    Cirillo P; Giallauria F; Di Palma V; Maresca F; Ziviello F; Bevilacqua M; Vigorito C; Trimarco B
    Angiology; 2013 Jul; 64(5):343-55. PubMed ID: 22942130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting high mobility group box 1 as a late-acting mediator of inflammation.
    Czura CJ; Tracey KJ
    Crit Care Med; 2003 Jan; 31(1 Suppl):S46-50. PubMed ID: 12544976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HMGB1 as a potential therapeutic target.
    Wang H; Li W; Goldstein R; Tracey KJ; Sama AE
    Novartis Found Symp; 2007; 280():73-85; discussion 85-91, 160-4. PubMed ID: 17380789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual roles for HMGB1: DNA binding and cytokine.
    Czura CJ; Wang H; Tracey KJ
    J Endotoxin Res; 2001; 7(4):315-21. PubMed ID: 11717586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-mobility-group box chromosomal protein 1 as a new target for modulating stress response.
    Suda K; Takeuchi H; Ishizaka A; Kitagawa Y
    Surg Today; 2010 Jul; 40(7):592-601. PubMed ID: 20582508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High mobility group box 1 protein, a cue for stem cell recruitment.
    Palumbo R; Bianchi ME
    Biochem Pharmacol; 2004 Sep; 68(6):1165-70. PubMed ID: 15313414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hmgb-1 as a therapeutic target for infectious and inflammatory disorders.
    Mantell LL; Parrish WR; Ulloa L
    Shock; 2006 Jan; 25(1):4-11. PubMed ID: 16369179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unraveling the role of high mobility group box protein 1 in severe trauma.
    Abraham E
    Crit Care; 2009; 13(6):1004. PubMed ID: 19930620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.